Safety of N-Acetylcysteine at High Doses in Chronic Respiratory Diseases: A Review

Tekijä Calverley, Peter, Rogliani, Paola, Papi, Alberto
Julkaisussa Drug Saf (2020)

Rate of Decline of FEV(1) as a Biomarker of Survival?

Tekijä Papi, Alberto, Beghé, Bianca, Fabbri, Leonardo M.
Julkaisussa Am J Respir Crit Care Med (2021)

Models of Respiratory Infections: Virus-Induced Asthma Exacerbations and Beyond

Tekijä Saturni, Sara, Contoli, Marco, Spanevello, Antonio, Papi, Alberto
Julkaisussa Allergy Asthma Immunol Res (2015)

The efficacy of extrafine beclomethasone dipropionate–formoterol fumarate in COPD patients who are not “frequent exacerbators”: a post hoc analysis of the FORWARD study

Tekijä Singh, Dave, Vezzoli, Stefano, Petruzzelli, Stefano, Papi, Alberto
Julkaisussa Int J Chron Obstruct Pulmon Dis (2017)

Pharmacokinetics and Safety of Single and Multiple Doses of Oral N-Acetylcysteine in Healthy Chinese and Caucasian Volunteers: An Open-Label, Phase I Clinical Study

Tekijä Papi, Alberto, Di Stefano, Andrea F. D., Radicioni, Milko
Julkaisussa Adv Ther (2020)

Impact of extrafine formulations of inhaled corticosteroids/long-acting beta-2 agonist combinations on patient-related outcomes in asthma and COPD

Tekijä Scichilone, Nicola, Benfante, Alida, Morandi, Luca, Bellini, Federico, Papi, Alberto
Julkaisussa Patient Relat Outcome Meas (2014)

Extrafine beclometasone diproprionate/formoterol fumarate: a review of its effects in chronic obstructive pulmonary disease

Tekijä Singh, Dave, Corradi, Massimo, Spinola, Monica, Petruzzelli, Stefano, Papi, Alberto
Julkaisussa NPJ Prim Care Respir Med (2016)

Mechanisms of rhinovirus-induced asthma

Tekijä Papadopoulos, Nikolaos G, Papi, Alberto, Psarras, Stelios, Johnston, Sebastian L
Julkaisussa Paediatr Respir Rev (2004)

Beclomethasone/formoterol fixed combination for the management of asthma: patient considerations

Tekijä Nicolini, Gabriele, Scichilone, Nicola, Bizzi, Andrea, Papi, Alberto, Fabbri, Leonardo M
Julkaistu 2008

Triple therapy (ICS/LABA/LAMA) in COPD: time for a reappraisal

Tekijä Vanfleteren, Lowie, Fabbri, Leonardo M, Papi, Alberto, Petruzzelli, Stefano, Celli, Bartolome
Julkaisussa Int J Chron Obstruct Pulmon Dis (2018)

Extrafine triple therapy delays COPD clinically important deterioration vs ICS/LABA, LAMA, or LABA/LAMA

Tekijä Singh, Dave, Fabbri, Leonardo M, Vezzoli, Stefano, Petruzzelli, Stefano, Papi, Alberto
Julkaisussa Int J Chron Obstruct Pulmon Dis (2019)

Circulating neutrophils levels are a predictor of pneumonia risk in chronic obstructive pulmonary disease

Tekijä Pascoe, Steven J., Papi, Alberto, Midwinter, Dawn, Lettis, Sally, Barnes, Neil
Julkaisussa Respir Res (2019)

Models of infection and exacerbations in COPD

Tekijä Papi, Alberto, Contoli, Marco, Gaetano, Caramori, Mallia, Patrick, Johnston, Sebastian L
Julkaisussa Curr Opin Pharmacol (2007)

Management of chronic refractory cough in adults

Tekijä Visca, Dina, Beghè, Bianca, Fabbri, Leonardo Michele, Papi, Alberto, Spanevello, Antonio
Julkaisussa Eur J Intern Med (2020)

New drugs targeting Th2 lymphocytes in asthma

Tekijä Caramori, Gaetano, Groneberg, David, Ito, Kazuhiro, Casolari, Paolo, Adcock, Ian M, Papi, Alberto
Julkaistu 2008

A randomized, double-blinded, double-dummy efficacy and safety study of budesonide–formoterol Spiromax® compared to budesonide–formoterol Turbuhaler® in adults and adolescents with...

Tekijä Virchow, J. Christian, Rodriguez-Roisin, Roberto, Papi, Alberto, Shah, Tushar P., Gopalan, Gokul
Julkaisussa BMC Pulm Med (2016)

Treatment strategies for asthma: reshaping the concept of asthma management

Tekijä Papi, Alberto, Blasi, Francesco, Canonica, Giorgio Walter, Morandi, Luca, Richeldi, Luca, Rossi, Andrea
Julkaisussa Allergy Asthma Clin Immunol (2020)

ICS/formoterol in the management of asthma in the clinical practice of pulmonologists: an international survey on GINA strategy

Tekijä Cruz, Álvaro A., Barile, Sara, Nudo, Elena, Brogelli, Laura, Guller, Patricia, Papi, Alberto
Julkaisussa Asthma Res Pract (2021)

Step-down from high dose fixed combination therapy in asthma patients: a randomized controlled trial

Tekijä Papi, Alberto, Nicolini, Gabriele, Crimi, Nunzio, Fabbri, Leonardo, Olivieri, Dario, Rossi, Andrea, Paggiaro, Pierluigi
Julkaistu 2012

The EFFECT trial: evaluating exacerbations, biomarkers, and safety outcomes with two dose levels of fluticasone propionate/formoterol in COPD

Tekijä Papi, Alberto, Jones, Paul W, Dalvi, Prashant S, McAulay, Kirsten, McIver, Tammy, Dissanayake, Sanjeeva
Julkaisussa Int J Chron Obstruct Pulmon Dis (2015)